▩ ID9606/2a-c: Dispositive eines Virus
Gilead to Buy Pharmasset for $11 Billion


Type: Webpage

Identifier:
DLIJKZGY
Description

Under the terms of the deal, Gilead Sciences will pay $137 a share in cash for Pharmasset, 89 percent above its closing share price on Friday.


Related people

de la Merced, Michael J. (creator)
Pollack, Andrew (creator)